EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Perforating Morphea: A Rare Association with Elastosis Perforans Serpiginosa

Malena Gergovska, Jana Dimitrova, Kristina Semkova, Vesselina Yanachkova

Dermato · 2026-11-02 · 6 (4) · 41

DOI: 10.3390/dermato6040041 ↗
AbstractBibliografische Angaben

Abstract

Elastosis perforans serpiginosa (EPS) is a rare acquired perforating dermatosis char acterized by trans-epidermal elimination of abnormal elastic fibers. Although EPS has been associated with inherited connective tissue disorders, certain medications and systemic diseases, its coexistence with morphea is exceptionally uncommon. A 62-year-old female with generalized morphea and Hashimoto thyroiditis developed painful, serpiginous hyperkeratotic papules within a gluteal sclerotic plaque. Histology revealed perforation of connective tissue elements and confirmed a distinct connection between the damaged elastic fibers in the perforation and the thickened morphoeic collagen bundles. Combination therapy with topical clobetasol propionate, emollients, and NB-UVB achieved partial clinical resolution, though new lesions emerged in adjacent morphea plaques four months post-treatment. Given the intimate anatomical relation, we conclude that this represents perforating morphea rather than a random overlap (as a secondary form of EPS). We present a rare clinicopathological association of elastosis perforans serpiginosa arising within morphea, accompanied by autoimmune thyroiditis. Hyperkeratotic lesions developing within morphea plaques warrant histological evaluation for EPS and extended follow-up to monitor for recurrence. To our knowledge, this is only the second documented case of co-occurring EPS and morphea.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →